No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs ...
Study finds similar safety regardless of anticoagulant type.In a study of adults with advanced prostate cancer taking androgen-receptor pathway ...
Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests. Using AI, scientists found that images ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results